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Abstract 
Background: Primacy performance in recall has been shown to predict cognitive decline in 
cognitively intact elderly, and conversion from mild cognitive impairment (MCI) to Alzheimer’s 
disease (AD). Delayed primacy performance, but not delayed non-primacy performance, has 
been shown to be associated with hippocampal volume in cognitively intact older individuals. 
Since presence of neurofibrillary tangles is an early sign of AD-related pathology, we set out to 
test whether cerebrospinal fluid (CSF) levels of tau had an effect on delayed primacy 
performance, while controlling for hippocampal volume and CSF Aβ 1-42 levels. 
Methods: Forty-seven individuals, 60 or older and cognitively intact, underwent a multi-session 
study including lumbar puncture, an MRI scan of the head and memory testing. 
Results: Our regression analyses show that CSF levels of hyperphosphorylated (P) tau are only 
associated with reduced delayed primacy performance when hippocampal volumes are smaller. 
Conclusion: Our findings suggest that hippocampal size may play a protective role against the 
negative effects of P tau on memory. 
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Background 
The identification of individuals at risk of AD during preclinical stages is critical for the 
implementation of early intervention strategies (1). Recently, episodic memory performance for 
primacy items (i.e., first few items on a study list) has been shown to provide predictive value for 
cognitive decline in both cognitively intact elderly (2), and conversion from MCI to AD (3). 
Primacy performance, especially in delayed memory tasks (e.g., after 20 minutes), is thought to 
reflect consolidation ability (4), a critical target function for prediction of subsequent 
neurodegeneration (5). Importantly, consolidation is thought to rely upon the hippocampal 
formation (6), whose integrity has also been examined in studies of AD prediction (e.g., 7-9). 
Finally, we have shown that hippocampal gray matter volume predicts delayed primacy 
performance, but not memory performance for other regions of the study list, in cognitively 
intact older individuals, thus confirming the link between hippocampus and memory for early list 
items (10). 
A key component of AD neuropathology is the presence of neurofibrillary tangles, which 
are typically observed in the medial temporal lobe (MTL) first, and in the hippocampus in 
particular (11). The degree of neurofibrillary tangle burden has been associated with levels of 
total (T) and P tau in clinical-postmortem comparison studies (12-14, but see 15), suggesting that 
in vivo CSF levels of T and P tau may serve as surrogate measures for the degree of hippocampal 
and cortical neurofibrillary pathology. CSF levels of T and P tau have been found to associate 
with short term memory performance in AD (16), and to correlate negatively with hippocampal 
volume both in individuals with AD (17) and MCI (18). Moreover, P tau is considered a key 
factor in entorhinal cortex degeneration in cognitively intact participants (19).  
For the reasons above, we set out to test whether delayed primacy performance – defined 
CSF tau and Delayed Primacy  
6  
as the first four words on the study list to maintain consistency with (2) – in cognitively intact 
individuals is associated with CSF levels of T and P tau. In particular, we expect that higher 
levels of P tau, which may reflect tangle pathology (20) affecting the hippocampus and cortical 
brain areas, will be associated with poorer primacy performance. Moreover, we explore whether 
the relationship between hippocampal size and delayed primacy performance (10) is moderated 
by CSF tau levels, whilst controlling also for CSF levels of amyloid beta (Aβ) 1–42, which 
provide an index of amyloid pathology (e.g., 14).  
Methods 
Subjects. Participants for the study were either recruited from the Memory Education and 
Research Initiative (MERI) program at the Nathan Kline Institute for Psychiatric Research 
(NKI), or via advertisements; recruitment was originally for a study on major depression disorder 
(MDD) in old age (see 21). The study was approved by the institutional review boards of the 
Nathan Kline Institute for Psychiatric Research and the New York University School of 
Medicine. All participants were paid up to $450.00 for their participation in the study, and 
provided formal consent prior to testing. A total of 133 participants were recruited for the study, 
although only 51 received a lumbar puncture from which CSF could be extracted. In order to 
maintain a cognitively intact sample, we excluded participants whose Mini-Mental State 
Examination (MMSE) score was below 28, and/or presented MRI evidence of confluent deep or 
periventricular white matter hyperintensities. These exclusion criteria left us with a total of 47 
participants, 28 of whom received a diagnosis of MDD from a board-certified psychiatrist (NP), 
and 19 were controls. 
CSF measurements. Aβ 1–42 CSF levels were analysed with electrochemiluminescence 
technology using the MS6000 Human Ab Ultra-Sensitive Kit (Meso Scale Discovery, 
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Gaithersburg, Md.). Both t and p Tau concentrations were determined using a sandwich enzyme-
linked immunosorbent assay (ELISA) (Innotest hTAU-Ag, Innogenetics, Ghent, Belgium) 
specifically constructed for all tau isoforms, irrespective of phosphorylation status. 
MRI Acquisition. The acquisition was performed on a 1.5 T Siemens Vision system (Erlangen, 
Germany) at the NKI. Images were acquired using a sagittal magnetization prepared rapid 
gradient-echo sequence [MPRAGE; repetition time (TR)/echo time (TE)=11.4/11.9 ms, 1 
excitation, (NEX), matrix=256 x 256, FOV=307 mm, 1.2mm3 isotropic voxel, 172 slices, no 
gap]. Evaluation of white matter hyperintensities was performed using a fluid attenuated 
inversion recovery sequence [FLAIR; TR/TE=9000/119 ms, inversion time=2400 ms, NEX=1, 
matrix 256 x 256, FOV=240 mm, slice thickness=4 mm, 1 mm gap]. 
MRI preprocessing and analysis. MRI data processing followed procedures described previously 
(22-23). Figure 1 illustrates the hippocampal regions of interest (ROIs). The total intracranial 
volume (TIV) was used in the statistical model to account for differences in head size (see 
below), and was calculated as the sum of the total segmented gray matter, white matter and 
cerebrospinal fluid volumes in native space. 
Insert Figure 1 here 
Procedure. The study was conducted at the NKI and at the Clinical and Translational Science 
Institute, NYU, over multiple visits. On the first visit, after informed consent was provided, 
volunteers were administered a general medical intake questionnaire, and had their vital signs 
measured; the MMSE score and the Hamilton Depression Rating (HAM-D) score, which 
measures severity of current depressive symptoms, were obtained during this visit. On a second 
visit, participants received an MRI scan of the head. Neuropsychological testing took place on a 
third visit, and memory performance was assessed at this stage with the Buschke Selective 
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Reminding Test (BSRT; 24). This test comprises a list of 16 unrelated nouns, presented orally to 
the participant at a rate of 2 seconds each. After presentation, participants were asked to freely 
recall as many items as possible, stopping once they feel no more items can be retrieved. In the 
delayed trial, which is the focus of our current examination (cf., 2), the free recall task occurs 
roughly after a 20-minute delay from the initial presentation. 
During a fourth and final session, a lumbar puncture was performed under guided fluoroscopy. 
Participants were asked to fast overnight and the procedure took place between 9:00 and 10:00 in 
the morning. A total of 15 ml of clear CSF was collected in three polypropylene tubes labelled 
“A” (first 5 ml), “B” (second 5 ml), and “C” (third 5 ml). The tubes were immediately placed on 
ice for a maximum of 1 hour until the samples were centrifuged at 4°C (at 1500 rpm) for 10 
minutes. Aliquots of 0.25 ml were subsequently placed into 1.00-ml polypropylene cryogenic 
vials and put into Nunc eight-cell storage boxes (Nalge Nunc International, Rochester, N.Y.) at –
80°C. All Aβ and tau determinations were performed from tube “C”. 
Study Design and Analysis. To test our hypothesis that P tau, either directly or via moderation 
with hippocampal gray matter volume, predicts delayed primacy performance, we carried out 
multiple linear regression analyses. The outcome variables, analyzed separately, were a) the 
proportion of primacy items (first four words; cf., 2) recalled in the delayed task of the BSRT 
task, and b) the proportion of non-primacy (all words recalled minus primacy words) items 
recalled in the same task. Both outcome variables were normally distributed based on assessment 
of skewness and kurtosis (25). The main predictor was CSF tau, either T or P in separate 
analyses to avoid multicollinearity (the correlation between T and P tau yielded an r coefficient 
of 0.968, p<0.001). Moreover, we also tested the tau (both T and P) by hippocampal volume 
moderation term in a separate model. Age; CSF Aβ 1-42; total hippocampal volume (mm3); total 
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intracranial volume (TIV; mm3) to control for head size; and HAM-D score to control for 
presence of current depressive symptoms, were used as control variables in a three-model 
procedure. Model 1 included all control variables, model 2 included the predictor, and model 3 
included the moderation term. Finally, all predictors and control variables were standardized. 
Insert Table 1 here 
Results 
Table 1 reports group demographics, CSF values and memory performance scores. The 
total N for T tau was 46 due to a missing value. No issues of multicollinearity were observed 
(variance inflation factor ≤ 2.628) in the regression analyses. Considering the mixed nature of 
our sample (i.e., individuals with MDD and controls), we evaluated the possibility that the 
HAM-D scores could be highly skewed (e.g., 0 values for all controls). However, visual 
exploration of the scores yielded no significant outliers, and z-scores for both skewness and 
kurtosis were within the typically accepted 1.96 threshold (≤ 1.80; 25). 
P tau was a significant predictor of delayed primacy performance, β = -.388, p = .022, but 
this relationship appears to be qualified by the interaction between P tau and hippocampal size, β 
= .354, p = .035. The interaction brought explained variance (R2) from 0.191 with model 1 and 2 
combined to 0.280 with model 3, for a 32% increase. Figure 2 shows that delayed primacy 
performance is unaffected by changes in P tau CSF levels at larger hippocampal volumes, but 
declines when the P tau levels are higher and the size of the hippocampus is smaller. These 
results suggest that hippocampal size may provide a form of protection against increases in P tau 
CSF levels.  
In contrast, neither P tau (only 0.009 variance explained over model 1), nor the moderation 
term (only 0.001 variance explained over model 2), nor any of the control variables appeared to 
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predict delayed non-primacy performance significantly. The closest predictor in this analysis was 
Aβ 1-42, β = .280, p = .090, suggesting that higher levels of CSF Aβ 1-42, which should index 
less amyloid pathology, may be associated with better memory performance for non-primacy 
items. 
Analogously to P tau, T tau showed marginal effects on delayed primacy both 
independently, β = -.336, p = .078, and as part of the interaction, β = .315, p = .072, although 
neither relationship is statistically significant. Also, once again, the closest significant predictor 
of non-primacy performance was CSF Aβ 1-42, β = .279, p = .095.  
Insert Figure 2 here 
Discussion 
Recent findings have shown that delayed free recall performance for early-list words (i.e., 
delayed primacy performance) may be predictive of cognitive decline in older individuals who 
are cognitively intact at baseline (2); and that, also in cognitively healthy participants, 
hippocampal gray matter volume is associated with delayed primacy, but not delayed non-
primacy, performance (10). These results are consistent with a burgeoning literature on the 
predictive and diagnostic value of serial position analysis, and primacy in particular (e.g., 3, 26-
27). In this study on cognitively intact elderly individuals, we have demonstrated for the first 
time that delayed primacy performance is also affected by CSF levels of P tau. P tau is a marker 
of neurofibrillary pathology, which is considered to be one of the first neuropathological events 
in AD, and is thought to be initiated in the MTL, including the hippocampus. Critically, we 
observed in our study an interaction effect between hippocampal gray volume and CSF P tau 
levels on delayed primacy performance. This interaction suggests that hippocampal size may act 
as a protective factor against the deleterious effects of P tau on delayed primacy performance. 
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A limitation of our present study is that the sample was made up of both participants with a 
diagnosis of MDD and healthy controls. MDD has been associated with poorer memory 
performance (e.g., 28) and reduced hippocampal volume (e.g., 29), and it is therefore possible 
that the combination of healthy and depressed participants may have confounded our results. 
However, considering that we controlled for the HAM-D score in all of our analyses, we feel 
quite confident that depressive symptoms did not significantly alter the pattern of our results. 
Another potential issue pertains to the possibility of a selection bias in CSF collection. As 
noted, out of 133 total participants, only 51 subjects consented to the lumbar puncture. The idea 
of having a lumbar puncture can be frightening, and all prospective participants are informed of 
the possible side-effects, such as bleeding and headaches. Therefore, it is not implausible that a 
systematic bias may be introduced in the study and that only certain participants (e.g., only 
highly motivated participants, or highly educated) may consent to the lumbar puncture. 
However, a basic comparison between consenters and non-consenters, showing no significant 
difference across groups in age, MMSE score or years of education (p≥.208), provides no 
evidence of a bias, although this possibility cannot be categorically ruled out.    
Attempts at investigating the relationship between hippocampal volume and episodic 
memory function in older adults have been met so far with high levels of variability across 
studies and little supporting evidence of a positive correlation between size and performance 
(30). Our results may help clarifying this issue. First of all, if the hippocampus is primarily 
involved with the retrieval of early list items, as suggested by Bruno et al. (10), then it is possible 
that studies that ignore serial position performance and focus exclusively on total list memory 
will find associations between hippocampal size and memory only when, incidentally, primacy 
and non-primacy outputs are highly correlated. For example, we can imagine three study 
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participants: Participant A recalls all primacy items (e.g., 4) and all non-primacy items (e.g., 12) 
for a total of 16 items; Participant B recalls 0 primacy items, but all non-primacy items for a total 
of 12; and Participant C recalls all primacy items, but 0 non-primacy items for a total of 4. In this 
example, and based on our conjecture of a preferential link between hippocampus and primacy, 
Participant C would be expected to have a larger hippocampus than Participant B despite a lower 
total memory score; additionally, Participant A would be expected to have roughly a similar-
sized hippocampus as Participant C, despite a much higher total score. This example illustrates 
how the issues of inter-study variability in examining the relationship between hippocampal 
volume and episodic memory ability may at least partly be related to differences in serial 
position effects. 
An alternative solution to the issue of inconsistency across studies may be found in our 
current results. A look a Figure 2 suggests that smaller hippocampal volumes are only associated 
with a reduction of memory performance, specifically delayed primacy, in the presence of high 
levels of P Tau. Therefore, it may be possible that hippocampal function, and consequently 
memory function, are roughly comparable across a wide range of hippocampal volumes as long 
as these remain above a certain size that we can consider to be “normal”. In contrast, when 
hippocampal volumes are smaller, they are only good estimators of individual hippocampal 
dysfunction, and therefore poorer memory, when they are also accompanied by a 
neurodegenerative process, such as, for example, macrostrustural hippocampal degeneration 
caused by neurofibrillary tangles. More research however is required to clarify these issues 
further. 
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Table 1. Demographics, CSF values and memory performance: Number of subjects (i.e., N); Age 
in years (mean and standard deviation); HDS score (mean and standard deviation); CSF levels 
of Aβ 1-42, T and P tau (mean and standard deviation); and proportions of primacy and non-
primacy performance (mean and standard deviation).  
 
  
N 47 
Age 67.13 (6.23) 
HDS 10.55 (11.01) 
Aβ 1-42 269.45 (158.93) 
T tau 296.02 (132.38)* 
P tau 50.00 (23.78) 
Primacy 0.64 (0.27) 
Non-primacy 0.54 (0.17) 
* Due to an undetermined value, the N for T tau is 46. 
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Figure 1. Hippocampal ROIs in Montreal Neurological Institute space. 
Figure 2. Plot of CSF P tau levels (X-axis) by proportion of delayed recalled primacy items (Y-
axis), as moderated by hippocampal gray matter volume. 
 
CSF tau and Delayed Primacy  
21  
Figure 1. 
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Figure 2.  
 
